During the past decade, Azienda Ospedaliera SS Antonio e Biagio conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 21 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 20 clinical trials were completed. i.e. 69% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera SS Antonio e Biagio" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 20 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 7 trials sponsored, "Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria" with 6 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored and "International Extranodal Lymphoma Study Group (IELSG)" with 6 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera SS Antonio e Biagio" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 6 trials as a collaborator, "PharmaMar" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera SS Antonio e Biagio" are "Myelodysplastic Syndromes" (9 trials), "Leukemia" (7 trials), "Acute Myeloid Leukemia" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Azienda Ospedaliera SS Antonio e Biagio" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera SS Antonio e Biagio" are "Drug" (92 trials), "Other" (13 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Rituximab" (6 trials), "cyclophosphamide" (5 trials), "radiation therapy" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera SS Antonio e Biagio" are 112 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 40 active trials in "Azienda Ospedaliera SS Antonio e Biagio". 2 are not yet recruiting, 16 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Azienda Ospedaliera SS Antonio e Biagio, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera SS Antonio e Biagio, 3 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Azienda Ospedaliera SS Antonio e Biagio has several departments that took part in Clinical trials: "Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica" - 3 trials